SGLT2 Inhibitors

SGLT2 Inhibitors – Invokana, Farxiga, and Jardiance

SGLT2 inhibitors, including Invokana and Farxiga, are a new type of diabetes medications that are prescribed to Type II diabetics as a means of helping to control blood sugar levels. Since their release to the general public, however, the FDA has reported 20 cases in which use of SGLT2 inhibitors has led to a dangerous condition known as ketoacidosis. Ketoacidosis can cause serious impairments and may even be fatal.